MEGAN ETTENSOHN: Open Payments
NPI 1134960784 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $123 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| TerSera Therapeutics LLC | 1 | $27 |
| ABBVIE INC. | 1 | $16 |
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $14 |
Products named: KISQALI, Xermelo, EMRELIS, FOTIVDA, Lenvima, NERLYNX.
Industry payments across IN — which companies pay providers there.
